B W Dunlop

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi request reprint Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive NE, 3rd Floor, Atlanta, GA, USA
    Trials 15:240. 2014
  2. pmc Posttraumatic stress disorder increases sensitivity to long term losses among patients with major depressive disorder
    Jan B Engelmann
    Department of Economics, University of Zurich, Zurich, Switzerland
    PLoS ONE 8:e78292. 2013
  3. pmc A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
    Neuropsychopharmacology 37:2830-6. 2012
  4. pmc Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1256 Briarcliff Road, Building A, 3rd Floor, Atlanta, GA 30306, USA
    Trials 13:106. 2012
  5. ncbi request reprint Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy
    Boadie W Dunlop
    Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA, USA
    Curr Pharm Des 18:5645-58. 2012
  6. pmc Recovery and subsequent recurrence in patients with recurrent major depressive disorder
    Boadie W Dunlop
    Emory University School of Medicine, 1256 Briarcliff Road, Building A, 3rd Floor, Atlanta, GA 30322, USA
    J Psychiatr Res 46:708-15. 2012
  7. pmc Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder
    Boadie W Dunlop
    Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30306, USA
    J Psychiatr Res 46:375-81. 2012
  8. ncbi request reprint Exercise for depression: efficacy, safety and clinical trial implications
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    Psychopharmacol Bull 41:65-75. 2008
  9. pmc The effects of sertraline on psychopathic traits
    Boadie W Dunlop
    Emory University School of Medicine, Atlanta, Georgia 30306, USA
    Int Clin Psychopharmacol 26:329-37. 2011
  10. doi request reprint Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo
    Boadie W Dunlop
    Emory University College of Medicine, Atlanta, GA 30322, USA
    J Clin Psychopharmacol 31:569-76. 2011

Detail Information

Publications26

  1. ncbi request reprint Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive NE, 3rd Floor, Atlanta, GA, USA
    Trials 15:240. 2014
    ..This Phase II trial aims to evaluate the efficacy of a CRH type 1 receptor (CRHR1) antagonist in the treatment of PTSD...
  2. pmc Posttraumatic stress disorder increases sensitivity to long term losses among patients with major depressive disorder
    Jan B Engelmann
    Department of Economics, University of Zurich, Zurich, Switzerland
    PLoS ONE 8:e78292. 2013
    ....
  3. pmc A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
    Neuropsychopharmacology 37:2830-6. 2012
    ..24, p=0.034) and response rate (β=2.26, p=0.035). Including a higher proportion of academic sites may increase the ability to detect differences between active drug and placebo in clinical trials of major depressive disorder...
  4. pmc Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1256 Briarcliff Road, Building A, 3rd Floor, Atlanta, GA 30306, USA
    Trials 13:106. 2012
    ..Consequently, we initiated a randomized clinical trial designed to identify factors that moderate response to three treatments for MDD among patients never treated previously for the condition...
  5. ncbi request reprint Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy
    Boadie W Dunlop
    Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA, USA
    Curr Pharm Des 18:5645-58. 2012
    ..The next few years promise to produce insight into the neurobiology and clinical efficacy of several novel approaches in the pharmacologic treatment and prevention of PTSD...
  6. pmc Recovery and subsequent recurrence in patients with recurrent major depressive disorder
    Boadie W Dunlop
    Emory University School of Medicine, 1256 Briarcliff Road, Building A, 3rd Floor, Atlanta, GA 30322, USA
    J Psychiatr Res 46:708-15. 2012
    ..We conclude that protection against recurrence derives from the degree and duration of recovery, particularly for patients maintained on antidepressant medication...
  7. pmc Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder
    Boadie W Dunlop
    Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30306, USA
    J Psychiatr Res 46:375-81. 2012
    ..Specific preferences for CBT or medication may reflect differing conceptualizations about depressive illness, knowledge of which may enhance treatment retention and efficacy...
  8. ncbi request reprint Exercise for depression: efficacy, safety and clinical trial implications
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    Psychopharmacol Bull 41:65-75. 2008
    ..Exercise as a treatment for depression carries both potential benefit for depressive symptoms and risk for adverse events. The design of clinical trials would be strengthened by consideration of these effects of exercise in the future...
  9. pmc The effects of sertraline on psychopathic traits
    Boadie W Dunlop
    Emory University School of Medicine, Atlanta, Georgia 30306, USA
    Int Clin Psychopharmacol 26:329-37. 2011
    ..Antidepressants reduce other, more maladaptive, traits associated with psychopathy, including dysregulated impulsivity and externalization...
  10. doi request reprint Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo
    Boadie W Dunlop
    Emory University College of Medicine, Atlanta, GA 30322, USA
    J Clin Psychopharmacol 31:569-76. 2011
    ..This is the first study to assess the efficacy of desvenlafaxine (administered as desvenlafaxine succinate) for improving depressive symptoms and functioning exclusively in employed patients with major depressive disorder (MDD)...
  11. pmc Will current socioeconomic trends produce a depressing future for men?
    Boadie W Dunlop
    Br J Psychiatry 198:167-8. 2011
    ..Men who assume a greater share of roles traditionally filled by women will experience challenges to traditional sources of male self-esteem, potentially heightening the risk for depressive disorders among men...
  12. pmc Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder
    Boadie W Dunlop
    Department of Psychiatry, Emory University School of Medicine, 1256 Briarcliff Road, Building A, 3rd Floor, Atlanta, GA 30306, USA
    J Psychiatr Res 45:96-103. 2011
    ..Poor agreement between patient- and clinician-ratings of depression severity is primarily a state phenomenon, although it is trait-like for some patients...
  13. pmc Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30322, USA
    J Psychiatr Res 45:24-8. 2011
    ..However, a comprehensive analysis of the safety of this test in psychiatric patients has not previously been performed...
  14. pmc Survey of investigators' opinions on the acceptability of interactions with patients participating in clinical trials
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
    J Clin Psychopharmacol 30:323-7. 2010
    ..We sought to explore what types of interactions with patients investigators considered to be appropriate during placebo-controlled pharmacotherapy studies of major depressive disorder...
  15. ncbi request reprint Tiagabine for social anxiety disorder
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30329, USA
    Hum Psychopharmacol 22:241-4. 2007
    ..Results of this pilot study suggest that tiagabine may be an option for the treatment of patients with SAD. Larger, controlled studies are required to fully elucidate the potential of tiagabine for the treatment of SAD...
  16. ncbi request reprint Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics
    Boadie W Dunlop
    Mood and Anxiety Disorders Program, Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30329, USA
    Psychopharmacol Bull 37:99-117. 2003
    ....
  17. ncbi request reprint Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30307, USA
    J Clin Psychopharmacol 27:614-9. 2007
    ..Previous studies suggest that adjunctive modafinil treatment provides benefit for patients with depression with significant sleepiness and fatigue...
  18. pmc A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders
    B W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30322, USA
    J Med Ethics 35:384-9. 2009
    ....
  19. pmc Correlation between patient and clinician assessments of depression severity in the PREVENT study
    Boadie W Dunlop
    Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA
    Psychiatry Res 177:177-83. 2010
    ..This study analyzed agreement between commonly used depression rating scales in the Prevention of Recurrent Episodes of Depression with Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial...
  20. pmc Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects
    G Andrew James
    Biomedical Imaging Technology Center, Department of Biomedical Engineering, Georgia Institute of Technology Emory University, Atlanta, GA 30322 4600, USA
    Neuroimage 45:778-87. 2009
    ..These results suggest that exploratory SEM is a viable technique for neuroimaging connectivity analyses of individual subjects' resting-state fMRI data...
  21. doi request reprint Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review
    Jeffrey J Rakofsky
    Department of Psychiatry and Behavioral Sciences, Mood and Anxiety Disorders Program Bipolar Disorders Clinic, Emory University, 1256 Briarcliff Rd, Atlanta, GA 30306, USA
    J Clin Psychiatry 72:81-90. 2011
    ..To review the evidence for treating anxiety in patients with bipolar disorder...
  22. ncbi request reprint Neurobiology and etiology of panic disorder
    Philip T Ninan
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    J Clin Psychiatry 66:3-7. 2005
    ..The lessons learned can guide the delivery of treatments to enhance the likelihood of achieving remission and the discovery of novel treatments for panic disorder...
  23. ncbi request reprint Use of dialectical behavior therapy in borderline personality disorder: a view from residency
    Binali Sharma
    Emory University School of Medicine, Atlanta, Georgia, USA
    Acad Psychiatry 31:218-24. 2007
    ..The authors describe the use of dialectical behavior therapy (DBT) in treating borderline personality disorder during psychiatry residency, and assess the status of DBT education within psychiatry residencies in the United States...
  24. ncbi request reprint The role of dopamine in the pathophysiology of depression
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University, 101 Woodruff Circle, Atlanta, GA 30322, USA
    Arch Gen Psychiatry 64:327-37. 2007
  25. ncbi request reprint Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population
    Erica Duncan
    Mental Health Service, Atlanta VA Medical Center, Decatur GA 30033, USA
    Int Clin Psychopharmacol 22:1-11. 2007
    ..These data indicate that patients with no previously observed glucose elevations develop diabetes-level hyperglycemia during antipsychotic treatment, particularly in patients receiving olanzapine...
  26. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
    Martin B Keller
    Brown University, Providence, Rhode Island 02906, USA
    Biol Psychiatry 62:1371-9. 2007
    ..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...